121 related articles for article (PubMed ID: 20034769)
1. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):404-9. PubMed ID: 20034769
[TBL] [Abstract][Full Text] [Related]
2. Influence of 1-D silica nanotubes as drug adsorbent on release behaviors of tulobuterol-loaded porous microcapsules.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2012 Apr; 92():240-5. PubMed ID: 22205063
[TBL] [Abstract][Full Text] [Related]
3. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin.
Park SJ; Kim KS; Kim SH
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):238-44. PubMed ID: 15979289
[TBL] [Abstract][Full Text] [Related]
5. Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):240-6. PubMed ID: 20621457
[TBL] [Abstract][Full Text] [Related]
6. Effect of oxygen plasma treatment on the release behaviors of poly(epsilon-caprolactone) microcapsules containing tocopherol.
Park SJ; Kim KS
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):138-42. PubMed ID: 15936181
[TBL] [Abstract][Full Text] [Related]
7. Effect of acid-base interaction between silica and fragrant oil in the PCL/PEG microcapsules.
Park SJ; Yang YJ; Lee HB
Colloids Surf B Biointerfaces; 2004 Oct; 38(1-2):35-40. PubMed ID: 15465302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
[TBL] [Abstract][Full Text] [Related]
9. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs.
Poletto FS; Jäger E; Ré MI; Guterres SS; Pohlmann AR
Int J Pharm; 2007 Dec; 345(1-2):70-80. PubMed ID: 17604922
[TBL] [Abstract][Full Text] [Related]
10. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
Embleton JK; Tighe BJ
J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
[TBL] [Abstract][Full Text] [Related]
11. Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
Donbrow M; Hoffman A; Benita S
J Microencapsul; 1995; 12(3):273-85. PubMed ID: 7650592
[TBL] [Abstract][Full Text] [Related]
12. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
Seremeta KP; Chiappetta DA; Sosnik A
Colloids Surf B Biointerfaces; 2013 Feb; 102():441-9. PubMed ID: 23010128
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of slow release ketoprofen microcapsules formulated into tablets and capsules.
el Khodairy KA; Eshra AG; Nada AH; Mortada SA
J Microencapsul; 1992; 9(3):365-73. PubMed ID: 1403487
[TBL] [Abstract][Full Text] [Related]
14. The incorporation and release of bovine serum albumin from poly-hydroxybutyrate-hydroxyvalerate microcapsules.
Atkins TW; Peacock J
J Microencapsul; 1996; 13(6):709-17. PubMed ID: 8933356
[TBL] [Abstract][Full Text] [Related]
15. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
[TBL] [Abstract][Full Text] [Related]
16. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
Papadimitriou S; Bikiaris D
J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
[TBL] [Abstract][Full Text] [Related]
17. Accelerated stability of sulphamethoxazole microcapsules coated with Eudragit RS 100 and Eudragit RL 100.
Basnet S; Ganesan M; Pal TK
Boll Chim Farm; 2002; 141(3):202-9. PubMed ID: 12197419
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro characterization of amifostine biodegradable microcapsules.
Pamujula S; Graves RA; Kishore V; Mandal TK
Eur J Pharm Biopharm; 2004 Mar; 57(2):213-8. PubMed ID: 15018977
[TBL] [Abstract][Full Text] [Related]
19. Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
Madhusudhan S; Panda AK; Parimalakrishnan S; Manavalan R; Manna PK
J Microencapsul; 2010; 27(4):281-91. PubMed ID: 20515261
[TBL] [Abstract][Full Text] [Related]
20. Preparation and release properties of biodegradable chitin microcapsules: I. Preparation of 6-mercaptopurine microcapsules by phase separation methods.
Mi FL; Tseng YC; Chen CT; Shyu SS
J Microencapsul; 1997; 14(1):15-25. PubMed ID: 8994072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
